Method of treating anemia by administering IL-1ra

The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also re...

Full description

Saved in:
Bibliographic Details
Main Authors Kay, Jonathan, McCabe, Dorothy, Newmark, Richard, Coccia, Marco A
Format Patent
LanguageEnglish
Published 11.01.2011
Online AccessGet full text

Cover

More Information
Summary:The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.